IgE-mediated cow's milk allergy in Brazilian children: Outcomes of oral food challenge

Imagem de Miniatura
Arquivos
art_AQUILANTE_IgEmediated_cows_milk_allergy_in_Brazilian_children_Outcomes_2023.PDF (271.35 KB)
Citações na Scopus
0
Tipo de produção
article
Data de publicação
2023
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER
Autores
BARP, Mariana Fernandes
MARTINS, Tatiana Paskin da Rosa
Citação
WORLD ALLERGY ORGANIZATION JOURNAL, v.16, n.5, article ID 100781, 8p, 2023
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background: Oral food challenge (OFC) is useful for diagnosing food allergies and assessing tolerance, but severe reactions may occur during the procedure.Objective: To characterize the frequency and severity of reactions during cow's milk (CM) OFCs.Methods: A cross-sectional study was conducted to analyze the outcome of cow's milk oral food challenges (CMOFCs) performed to confirm IgE-mediated CM allergy or to assess food tolerance. CM was given first as baked milk (BM), followed by whole CM if there was no prior reaction to BM. An OFC was considered positive if IgE-mediated symptoms developed up to 2 h after ingestion. Symptoms were described and variables including age at OFC, prior anaphylaxis, other atopic diseases, and skin test results were compared according to the OFC outcomes.Results: A total of 266 CMOFCs were performed, including 159 patients with a median age of 6.3 years old. One hundred thirty-six tests were positive and 62 resulted in anaphylaxis. Thirty-nine anaphylactic reactions were observed up to 30 min after the first dose. Severe anaphylaxis (car-diovascular and/or neurological involvement) was reported in 5 tests. A second dose of epinephrine was required in 3 tests, and 1 presented a biphasic response. Younger patients had a higher risk of anaphylaxis during baked milk oral food challenge (BMOFC) (p = 0.009). The fre-quency of anaphylaxis was higher in patients submitted to BM (p = 0.009).Conclusions: Anaphylaxis is a known complication of CMOFCs even when there is no prior anaphylaxis or when conducted with baked products. This study reinforces the importance of conducting OFC in appropriate settings with a well-trained team.
Palavras-chave
Milk allergy, Immunotherapy, Anaphylaxis, Epinephrine, Children, Adolescent
URI
https://observatorio.fm.usp.br/handle/OPI/54959
Referências
  1. Abrams EM, 2017, ALLERGY ASTHMA CL IM, V13, DOI 10.1186/s13223-017-0215-8
  2. Ahrens B, 2014, CLIN EXP ALLERGY, V44, P572, DOI 10.1111/cea.12284
  3. Ahrens B, 2012, J ALLERGY CLIN IMMUN, V130, P549, DOI 10.1016/j.jaci.2012.05.045
  4. Akuete K, 2017, ANN ALLERGY ASTHMA I, V119, P1
  5. Barbosa CPG, 2017, ALLERGOL IMMUNOPATH, V45, P283, DOI 10.1016/j.aller.2016.10.008
  6. Bird JA, 2020, J ALLERGY CLIN IMMUN, V8, P17
  7. Bock SA, 2001, J ALLERGY CLIN IMMUN, V107, P191, DOI 10.1067/mai.2001.112031
  8. Brown SGA, 2013, J ALLERGY CLIN IMMUN, V132, P1141, DOI 10.1016/j.jaci.2013.06.015
  9. Campbell RL, 2015, J ALLER CL IMM-PRACT, V3, P576, DOI 10.1016/j.jaip.2015.04.009
  10. Capucilli P, 2018, ANN ALLERG ASTHMA IM, V121, P580, DOI 10.1016/j.anai.2018.07.018
  11. Castro AP, 2015, ALLERGOL IMMUNOPATH, V43, P67, DOI 10.1016/j.aller.2013.09.012
  12. Cox AL, 2018, CURR ALLERGY ASTHM R, V18, DOI 10.1007/s11882-018-0825-3
  13. Cuomo B, 2017, ITAL J PEDIATR, V43, DOI 10.1186/s13052-017-0410-8
  14. Dang AT, 2020, WORLD ALLERGY ORGAN, V13, DOI 10.1016/j.waojou.2020.100100
  15. Neves FVD, 2016, REV ASSOC MED BRAS, V62, P537, DOI 10.1590/1806-9282.62.06.537
  16. DunnGalvin A, 2013, J ALLERGY CLIN IMMUN, V131, P230, DOI 10.1016/j.jaci.2012.08.051
  17. DunnGalvin A, 2011, J ALLERGY CLIN IMMUN, V127, P633, DOI 10.1016/j.jaci.2010.12.004
  18. Flom JD, 2019, NUTRIENTS, V11, DOI 10.3390/nu11051051
  19. Gupta RS, 2011, PEDIATRICS, V128, pE9, DOI 10.1542/peds.2011-0204
  20. Gushken AKF, 2013, ALLERGOL IMMUNOPATH, V41, P94, DOI 10.1016/j.aller.2011.12.002
  21. Heinzerling Lucie, 2013, Clin Transl Allergy, V3, P3, DOI 10.1186/2045-7022-3-3
  22. Horimukai K, 2015, ALLERGY, V70, P334, DOI 10.1111/all.12562
  23. Jarvinen KM, 2008, J ALLERGY CLIN IMMUN, V122, P133, DOI 10.1016/j.jaci.2008.04.031
  24. Jarvinen KM, 2009, J ALLERGY CLIN IMMUN, V124, P1267, DOI 10.1016/j.jaci.2009.10.006
  25. Kawahara T, 2019, EUR J PEDIATR, V178, P181, DOI 10.1007/s00431-018-3274-z
  26. Lee J, 2013, ALLERGY ASTHMA PROC, V34, P220, DOI 10.2500/aap.2013.34.3669
  27. Leonard SA, 2015, J ALLER CL IMM-PRACT, V3, P13, DOI 10.1016/j.jaip.2014.10.001
  28. Lieberman JA, 2011, J ALLERGY CLIN IMMUN, V128, P1120, DOI 10.1016/j.jaci.2011.07.012
  29. Mankad VS, 2008, ANN ALLERG ASTHMA IM, V100, P469, DOI 10.1016/S1081-1206(10)60473-5
  30. Noone S, 2015, J ALLER CL IMM-PRACT, V3, P424, DOI 10.1016/j.jaip.2014.10.008
  31. Nowak-Wegrzyn A, 2008, J ALLERGY CLIN IMMUN, V122, P342, DOI 10.1016/j.jaci.2008.05.043
  32. Nowak-Wegrzyn A, 2018, J ALLER CL IMM-PRACT, V6, P486, DOI 10.1016/j.jaip.2017.10.021
  33. Pepys J, 1975, BRIT J HOSP MED, V14, P412
  34. Perry TT, 2004, J ALLERGY CLIN IMMUN, V114, P1164, DOI 10.1016/j.jaci.2004.07.063
  35. Perry TT, 2004, J ALLERGY CLIN IMMUN, V114, P144, DOI 10.1016/j.jaci.2004.04.009
  36. Rolinck-Werninghaus C, 2012, ALLERGY, V67, P951, DOI 10.1111/j.1398-9995.2012.02838.x
  37. Rona RJ, 2007, J ALLERGY CLIN IMMUN, V120, P638, DOI 10.1016/j.jaci.2007.05.026
  38. Sampson HA, 2003, PEDIATRICS, V111, P1601
  39. SAMPSON HA, 1992, NEW ENGL J MED, V327, P380, DOI 10.1056/NEJM199208063270603
  40. Sampson Hugh A, 2006, J Allergy Clin Immunol, V117, P391, DOI 10.1016/j.jaci.2005.12.1303
  41. Schoemaker AA, 2015, ALLERGY, V70, P963, DOI 10.1111/all.12630
  42. Sicherer SH, 2018, J ALLERGY CLIN IMMUN, V141, P41, DOI 10.1016/j.jaci.2017.11.003
  43. Spergel JM, 2004, ANN ALLERG ASTHMA IM, V92, P217, DOI 10.1016/S1081-1206(10)61550-5
  44. Sporik R, 2000, CLIN EXP ALLERGY, V30, P1540, DOI 10.1046/j.1365-2222.2000.00928.x
  45. Sugiura S, 2017, ALLERGOL INT, V66, P493, DOI 10.1016/j.alit.2016.11.005
  46. Tsuang A, 2018, ANN ALLERG ASTHMA IM, V121, P469, DOI 10.1016/j.anai.2018.06.015
  47. Vitalpur G, 2016, ALLERGY ASTHMA CL IM, V12, DOI 10.1186/s13223-016-0125-1
  48. Wainstein BK, 2010, PEDIAT ALLERG IMM-UK, V21, P603, DOI 10.1111/j.1399-3038.2010.01063.x
  49. Wang J, 2016, ALLERGY ASTHMA PROC, V37, P439, DOI 10.2500/aap.2016.37.3997
  50. Yanagida N, 2018, PEDIAT ALLERG IMM-UK, V29, P417, DOI 10.1111/pai.12896
  51. Yanagida N, 2017, INT ARCH ALLERGY IMM, V172, P173, DOI 10.1159/000458724
  52. Yanagida N, 2017, INT ARCH ALLERGY IMM, V172, P116, DOI 10.1159/000456008

Coleções
Artigos e Materiais de Revistas Científicas - HC/ICr
Artigos e Materiais de Revistas Científicas - LIM/36